soul trial oral semaglutide cardiovascular outcomes 2024 2025 of and tirzepatide for patients with type 2 diabetes in clinical practice ADA 2025: Oral Semaglutide Demonstrates

US$ 25.24

★★★★★ 4.1 (7 reviews)

US$ 26.88

★★★★★ 4.3 (19 reviews)

US$ 22.47

★★★★★ 4.5 (9 reviews)

US$ 24.80

★★★★★ 4.7 (19 reviews)

US$ 25.01

★★★★★ 4.0 (6 reviews)

US$ 23.40

★★★★★ 4.8 (30 reviews)

US$ 23.14

★★★★★ 4.3 (27 reviews)

US$ 28.75

★★★★★ 5.0 (16 reviews)

US$ 29.58

★★★★★ 4.1 (17 reviews)

US$ 25.26

★★★★★ 4.9 (24 reviews)

US$ 29.50

★★★★★ 5.0 (29 reviews)

US$ 23.24

★★★★★ 4.7 (24 reviews)

US$ 24.53

★★★★★ 4.7 (16 reviews)

US$ 25.53

★★★★★ 4.5 (13 reviews)

US$ 22.10

★★★★★ 4.4 (9 reviews)

US$ 21.79

★★★★★ 4.0 (12 reviews)

US$ 20.92

★★★★★ 4.6 (9 reviews)

US$ 27.36

★★★★★ 4.0 (10 reviews)

US$ 28.05

★★★★★ 4.2 (6 reviews)

US$ 26.06

★★★★★ 4.4 (29 reviews)